Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Tablets × Head & Neck × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Breast 3 Genitourinary 2 Lymphoid 1 Head & Neck 1

Conditions

Parathyroid Neoplasms 1 Hyperparathyroidism, Primary 1

Interventions

Cisplatin 118 Radiotherapy 57 Fluorouracil 41 Radiotherapy, Intensity-Modulated 40 Docetaxel 35 Gemcitabine 31 Cetuximab 28 Carboplatin 23 Capecitabine 20 pembrolizumab 19 Drug Therapy 15 Paclitaxel 13 toripalimab 12 Surgical Procedures, Operative 9 Nivolumab 9 nimotuzumab 8 camrelizumab 8 Magnetic Resonance Spectroscopy 8 Chemoradiotherapy 8 nedaplatin 7 Methotrexate 7 tislelizumab 6 Standard of Care 6 Specimen Handling 6 Radiation 6 Platinum 6 Neoadjuvant Therapy 6 Iodine-131 6 Induction Chemotherapy 6 Gabapentin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed

46 enrolled 49 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡